The timing of drug ingestion over 24 hours was assessed in 58 outpatients taking drugs three times daily. The mean time between 1st and 2nd dose was 5.7 hours, 2nd and 3rd 6.1 hours and between 3rd and 1st of the next day 12.2 hours. Based on a simulation of hydralazine pharmacokinetics, such irregular administration would increase peak levels by 10% and decrease trough levels by 64% compared with regular 8-hourly doses.
Introduction
High plasma levels of a drug may be associated with adverse reactions and consequent lack of compliance, while low levels may result in failure to maintain a minimum therapeutic level and loss of efficacy. Plasma levels are not only determined by the dose of drug and its rate of absorption, distribution and elimination, but also depend upon the time and interval between individual doses. We have therefore investigated the variability in the time of ingestion of drugs over 24 hours and assessed the effect on plasma drug concentration. the nearest hour, the times they had taken their prescribed drugs during the preceding day. No prior warning of the questioning was given. The time between individual doses was then calculated.
Fifty-eight patients were receiving at least one drug thrice daily. The intervals between the three doses in the 24 hours are shown in Figure 1 . The mean interval between 1st and 2nd dose was 5.7 hours, 2nd and 3rd 6.1 hours, and between 3rd and 1st of the next day 12.2 hours.
A simulation of the pharmacokinetics of hydralazine was performed, using data from Talseth' and a two-compartment open model, and assuming linear kinetics. Predicted plasma levels of the drug when administered at 6-, 6-and 12-hourly intervals, as observed in our patients, were compared to those during a regular 8-hourly regimen. Peak levels were increased by 10% by irregular administration, while trough levels after the long 12-hour interval were 64% lower than those achieved after regular 8-hourly doses. Thus in our patients the lowest drug levels would commonly occur in the early morning. The Royal Society of Medicine ary and drugs with a short half-life are prescribed, specific advice on 8-hourly drug administration should be given, or preferably a sustained-release preparation used.
